Jacobs Levy Equity Management’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.3M	Hold	82,268	–	–	0.01%	560
2025 Q4	$3.08M	Sell	82,268 -157,504	-66%	-$5.18M	0.01%	510
2025 Q3	$6.61M	Sell	239,772 -21,854	-8%	-$753K	0.03%	368
2025 Q2	$8.27M	Sell	261,626 -39,098	-13%	-$1.26M	0.03%	337
2025 Q1	$9.98M	Sell	300,724 -12,289	-4%	-$441K	0.04%	339
2024 Q4	$10.8M	Buy	313,013 +88,532	+39%	+$3.04M	0.04%	293
2024 Q3	$8.98M	Sell	224,481 -20,845	-8%	-$732K	0.03%	341
2024 Q2	$7.4M	Buy	245,326 +7,999	+3%	+$241K	0.03%	381
2024 Q1	$7.97M	Sell	237,327 -1,408	-0.6%	-$45.2K	0.04%	338
2023 Q4	$7.71M	Buy	238,735 +3,847	+2%	+$107K	0.04%	345
2023 Q3	$7.7M	Sell	234,888 -51,136	-18%	-$1.78M	0.05%	299
2023 Q2	$10.1M	Sell	286,024 -90,362	-24%	-$3.12M	0.06%	279
2023 Q1	$12.3M	Sell	376,386 -2,641	-0.7%	-$120K	0.08%	256
2022 Q4	$20.9M	Sell	379,027 -42,138	-10%	-$2.32M	0.14%	185
2022 Q3	$18.7M	Buy	+421,165	New	+$20.5M	0.15%	177